Home

JPMorgan Chase Funding Inc.

CIK 1364743 · last filed 2025-10-24

JPMorgan Chase Funding Inc. is a corporate insider who has filed 24 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for SKYQ, was dated Oct 24, 2025. Across all open-market trades the lifetime net is +$7.3M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $751.7K across reported positions. The firm reports its address in New York, NY.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$751.7K

Companies

5

Total Filings

24

Lifetime Open-Market Net

$7.29M

Filer Profile

Reported Address
383 MADISON AVENUE
NEW YORK, NY 10179
Phone
(201) 595-6884
State of Incorporation
DE
Formerly Known As
J.P. Morgan Ventures CORP (2006–2013)
Related Filers
Bear Stearns Companies Inc. 2008 Trust — same reported address
CVC II Partners, LLC — same reported address
Doral GP Ltd. — same reported address
Doral Holdings, L.P. — same reported address
J.P. Morgan Securities LLC — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SKYQ 10%+ Owner 281,235 $2.67 $751.7K $0 1 2025-10-24
CANDELA CORP /DE/ (CLZR) Delisted 10%+ Owner 1,590,000 — — $7.43M 11 2008-10-10
ALPHARMA INC (ALO) Delisted 10%+ Owner 419,170 — — -$916.3K 1 2008-08-20
CHINDEX INTERNATIONAL INC (CHDX) Delisted 10%+ Owner — — — $0 1 2008-01-14
CYTOGEN CORP (CYTO) Delisted 10%+ Owner 61 $0.30 $18 $774.7K 7 2007-12-19

Recent Filings

24 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-10-24 SKYQ — — $0 EDGAR
2019-10-28 — Buy (P) — $0
2019-09-27 — Buy (P) — $0
2008-10-10 CANDELA CORP /DE/ (CLZR) Delisted Sell (S) −1,510,000 -$1.60M EDGAR
2008-10-06 CANDELA CORP /DE/ (CLZR) Delisted Sell (S) −264,000 -$508.7K EDGAR
2008-08-20 ALPHARMA INC (ALO) Delisted Sell (S) −38,000 -$916.3K EDGAR
2008-05-12 — Other (J) −4,919,000 -$3.05M
2008-01-14 CHINDEX INTERNATIONAL INC (CHDX) Delisted Other (J) — $0 EDGAR
2007-12-19 CYTOGEN CORP (CYTO) Delisted Buy (P) +54,000 $27.0K EDGAR
2007-12-14 CYTOGEN CORP (CYTO) Delisted Buy (P) +141,000 $75.6K EDGAR
Showing 1–10 of 24
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.